Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

A New Risk Scheme to Predict Warfarin-Associated Hemorrhage The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study.

18:18 EDT 24th April 2014 | BioPortfolio

Summary of "A New Risk Scheme to Predict Warfarin-Associated Hemorrhage The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study."

The purpose of this study was to develop a risk stratification score to predict warfarin-associated hemorrhage.

Affiliation

Department of Medicine, University of California, San Francisco, San Francisco, California.

Journal Details

This article was published in the following journal.

Name: Journal of the American College of Cardiology
ISSN: 1558-3597
Pages: 395-401

Links

PubMed Articles [11062 Associated PubMed Articles listed on BioPortfolio]

A National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation.

Anticoagulation control with warfarin, as assessed by the international normalized ratio (INR), is challenging. Time in the therapeutic range (TTR) has been inversely correlated with major hemorrhage,...

Rivaroxaban does not increase hemorrhage after thrombolysis in experimental ischemic stroke.

The management of acute ischemic stroke during anticoagulation with a novel oral anticoagulant (NOAC) is challenging because intravenous thrombolysis is contraindicated because of a putative increased...

Telephone-based anticoagulation management in the homebound setting: a retrospective observational study.

Anticoagulation management is currently performed through anticoagulation clinics or self-managed with or without the help of medical services. Homebound patients are a unique population that cannot u...

The effects of fasting in muslim patients taking warfarin.

Anticoagulation with warfarin is influenced by dietary changes but the effect of fasting on warfarin therapy is unknown.

Restarting Anticoagulation and Outcomes After Major Gastrointestinal Bleeding in Atrial Fibrillation.

Data regarding the outcomes of restarting anticoagulation in patients who develop gastrointestinal bleeding (GIB) while anticoagulated are sparse. We hypothesized that restarting anticoagulation in th...

Clinical Trials [2613 Associated Clinical Trials listed on BioPortfolio]

Low Dose Supplementation to Improve Anticoagulation Control With Oral Vitamin K as an Adjuvant to Warfarin Therapy

The main objective of this study is to assess the effectiveness of low dose Vitamin K1 (200 micrograms per day) at improving anticoagulation control in unstable patients on warfarin. This...

Clarification of Optimal Anticoagulation Through Genetics

Individuals taking warfarin often need frequent dose changes as the INR gets too high or too low which could result in a higher risk of thromboembolism, bleeding and early discontinuation...

The Relationship Between Osteoporosis and Chronic Oral Anticoagulation Therapy With Warfarin

The purpose of this study is to determine if osteoporosis is an unrecognized complication of chronic anticoagulation with warfarin.

Testing Strategies to Improving Warfarin Adherence

We are performing a research study to learn more about the control of an individual's blood thinning (anticoagulation) on warfarin. Individuals from an anticoagulation clinic are being as...

Patient Self Testing of Warfarin Therapy

To test the hypothesis that home international normalised ratio (INR) monitoring with supervised patient self-testing (PST)can provide comparable or superior time in therapeutic range (TTR...

Medical and Biotech [MESH] Definitions

An anticoagulant that acts by inhibiting the synthesis of vitamin K-dependent coagulation factors. Warfarin is indicated for the prophylaxis and/or treatment of venous thrombosis and its extension, pulmonary embolism, and atrial fibrillation with embolization. It is also used as an adjunct in the prophylaxis of systemic embolism after myocardial infarction. Warfarin is also used as a rodenticide.

The application of molecular biology to the answering of epidemiological questions. The examination of patterns of changes in DNA to implicate particular carcinogens and the use of molecular markers to predict which individuals are at highest risk for a disease are common examples.

A scheme which provides reimbursement for the health services rendered, generally by an institution, and which provides added financial rewards if certain conditions are met. Such a scheme is intended to promote and reward increased efficiency and cost containment, with better care, or at least without adverse effect on the quality of the care rendered.

Reduction of high-risk choices and adoption of low-risk quantity and frequency alternatives.

Hemorrhage within the orbital cavity, posterior to the eyeball.

Search BioPortfolio: